Solid Biosciences (SLDB) Non-cash Items (2018 - 2026)
Quarterly results put Non-cash Items at $5.4 million for Q1 2026, up 305.59% from a year ago — trailing twelve months through Mar 2026 was $5.4 million (up 305.59% YoY), and the annual figure for FY2025 was $1.1 million, up 458.03%.
Solid Biosciences has reported Non-cash Items over the past 6 years, most recently at $5.4 million for Q1 2026.
- Non-cash Items reached $5.4 million in Q1 2026 per SLDB's latest filing, up from $1.1 million in the prior quarter.
- Across five years, Non-cash Items topped out at $5.4 million in Q1 2026 and bottomed at $193000.0 in Q4 2024.
- Median Non-cash Items over the past 4 years was $1.0 million (2024), compared with a mean of $1.5 million.
- The largest annual shift saw Non-cash Items tumbled 77.64% in 2024 before it surged 458.03% in 2025.
- Over 4 years, Non-cash Items stood at $863000.0 in 2023, then crashed by 77.64% to $193000.0 in 2024, then soared by 458.03% to $1.1 million in 2025, then skyrocketed by 404.27% to $5.4 million in 2026.
- Business Quant data shows Non-cash Items for SLDB at $5.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.43 Mn |
| Mar 31, 2026 | 5.43 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 467,000.00 |
| Jun 30, 2025 | 467,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 193,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 998,150.00 |
| Jun 30, 2024 | 998,150.00 |
| Dec 31, 2023 | 863,000.00 |
| Dec 31, 2023 | 863,000.00 |
| Dec 31, 2020 | 910,000.00 |
| Dec 31, 2020 | 910,000.00 |
| Dec 31, 2018 | 2.26 Mn |
| Dec 31, 2018 | 2.26 Mn |